Energenesis Biomedical CO.,LTD. (6657.TW)

TWD 62.8

(7.72%)

Total Liabilities Summary of Energenesis Biomedical CO.,LTD.

  • Energenesis Biomedical CO.,LTD.'s latest annual total liabilities in 2023 was 24.58 Million TWD , down -13.14% from previous year.
  • Energenesis Biomedical CO.,LTD.'s latest quarterly total liabilities in 2024 Q2 was 27.48 Million TWD , down -13.9% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported annual total liabilities of 28.3 Million TWD in 2022, down -15.34% from previous year.
  • Energenesis Biomedical CO.,LTD. reported annual total liabilities of 33.43 Million TWD in 2021, up 2.8% from previous year.
  • Energenesis Biomedical CO.,LTD. reported quarterly total liabilities of 31.91 Million TWD for 2024 Q1, up 29.81% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported quarterly total liabilities of 25.76 Million TWD for 2023 Q3, down -42.25% from previous quarter.

Annual Total Liabilities Chart of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Historical Annual Total Liabilities of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 24.58 Million TWD -13.14%
2022 28.3 Million TWD -15.34%
2021 33.43 Million TWD 2.8%
2020 32.52 Million TWD 19.96%
2019 27.11 Million TWD 0.0%

Peer Total Liabilities Comparison of Energenesis Biomedical CO.,LTD.

Name Total Liabilities Total Liabilities Difference
Apex Biotechnology Corp. 500.07 Million TWD 95.083%
Sinphar Pharmaceutical Co.,Ltd. 2.85 Billion TWD 99.138%
Panion & Bf Biotech Inc. 1.32 Billion TWD 98.143%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 1.82 Billion TWD 98.65%
GenMont Biotech Incorporation 204.05 Million TWD 87.951%
Abnova (Taiwan) Corporation 69.42 Million TWD 64.584%
Adimmune Corporation 3.7 Billion TWD 99.337%
Tanvex BioPharma, Inc. 1.94 Billion TWD 98.734%
Polaris Group 1.46 Billion TWD 98.321%
UnicoCell Biomed Co., Ltd. 89.48 Million TWD 72.525%
PELL Bio-Med Technology Co. Ltd. 236.76 Million TWD 89.615%